comparemela.com

Latest Breaking News On - Kyle mikson - Page 14 : comparemela.com

Exagen Inc (XGN) CEO Ron Rocca on Q1 2022 Results - Earnings Call Transcript

Exagen Inc. (NASDAQ:NASDAQ:XGN) Q1 2022 Earnings Conference Call May 11, 2022 16:30 ET Company Participants Ryan Douglas - Investor Relations Ron Rocca - President and Chief Executive.

United statesRon roccaWalters kluwerKamal adawiKyle miksonBrian weinsteinRyan douglasMark hazeltineWilliam blairExchange commissionCompany participantsAmerican medical associationQueen mary university of londonExagen incLupus foundation of americaConference call may

Exagen Inc (XGN) Q1 2022 Earnings Call Transcript

XGN earnings call for the period ending March 31, 2022.

United statesRon roccaWalters kluwerKamal adawiKyle miksonBrian weinstein william blairBrian weinsteinRyan douglasKyle mikson canaccord genuityMark hazeltineWilliam blairExchange commissionAmerican medical associationQueen mary university of londonExagen incLupus foundation of america

Biodesix, Inc (BDSX) Q1 2022 Earnings Call Transcript

BDSX earnings call for the period ending March 31, 2022.

Robin harper cowieKyle miksonChris brinzeyMax masucciBrian weinstein william blairScott huttonBrian weinsteinMax masucci cowenKyle mikson canaccord genuityNeil vibhakar morgan stanleyWilliam blairMorgan stanleyExchange commission onFleischner societyBiodesix incCleveland clinic foundation

Quantum-Si incorporated (QSI) Q1 2022 Results - Earnings Call Transcript

Quantum-Si incorporated (NASDAQ:NASDAQ:QSI) Q1 2022 Earnings Conference Call May 09, 2022 04:30 PM ET Company Participants Juan Avendano - Head, IR Jonathan Rothberg - Interim CEO Claudia.

Garnet valleyUnited statesCanaccord genuityJonathan rothbergKyle miksonJuan avendanoClaudia draytonPatrick schneiderExchange commissionCompany participantsConference call mayChief operatingQuantum si firstInvestor relationsInterim chief executive officerChief operating officer

Castle Biosciences, Inc (CSTL) CEO Derek Maetzold on Q1 2022 Results - Earnings Call Transcript

Castle Biosciences, Inc. (NASDAQ:NASDAQ:CSTL) Q1 2022 Results Conference Call May 9, 2022 4:30 PM ET Company Participants Camilla Zuckero - Executive Director of Investor Relations and.

United statesCatherine schulteKyle miksonThomas flatenMark massaroCamille schrierPuneet soudaDerek maetzoldMason carricoCastle biosciencesFrank stokesCamilla zuckeroPrasad iyerCompany participantsNational cancer instituteCastle biosciences inc

vimarsana © 2020. All Rights Reserved.